57 related articles for article (PubMed ID: 14530682)
1. Budding is useful to select high-risk patients in stage II well-differentiated or moderately differentiated colon adenocarcinoma.
Okuyama T; Nakamura T; Yamaguchi M
Dis Colon Rectum; 2003 Oct; 46(10):1400-6. PubMed ID: 14530682
[TBL] [Abstract][Full Text] [Related]
2. The prognostic value of tumor budding in a thoroughly characterized stage II colon cancer population in the context of a national screening program.
Pihlmann Kristensen M; Korsgaard U; Timm S; Hansen TF; Zlobec I; Hager H; Kjær-Frifeldt S
Hum Pathol; 2024 Apr; 146():15-22. PubMed ID: 38428823
[TBL] [Abstract][Full Text] [Related]
3. Myxoid stroma is associated with postoperative relapse in patients with stage II colon cancer.
Okuyama T; Sameshima S; Takeshita E; Mitsui T; Noro T; Ono Y; Noie T; Ban S; Oya M
BMC Cancer; 2020 Sep; 20(1):842. PubMed ID: 32883261
[TBL] [Abstract][Full Text] [Related]
4. Obesity and early-onset colorectal cancer risk: emerging clinical evidence and biological mechanisms.
Xu P; Tao Z; Yang H; Zhang C
Front Oncol; 2024; 14():1366544. PubMed ID: 38764574
[TBL] [Abstract][Full Text] [Related]
5. Clinicopathological Significances and Prognostic Role of Intratumoral Budding in Colorectal Cancers.
Kang G; Pyo JS; Kim NY; Kang DW
J Clin Med; 2022 Sep; 11(19):. PubMed ID: 36233405
[TBL] [Abstract][Full Text] [Related]
6. Tumor budding as a prognostic indicator in colorectal carcinoma: a retrospective study of primary colorectal carcinoma cases in a tertiary care center.
Shah AH; Gami AJ; Desai NH; Gandhi JS; Trivedi PP
Indian J Surg Oncol; 2022 Sep; 13(3):459-467. PubMed ID: 36187533
[TBL] [Abstract][Full Text] [Related]
7. Novel Criteria for Intratumoral Budding with Prognostic Relevance for Colon Cancer and Its Histological Subtypes.
Pour Farid P; Eckstein M; Merkel S; Grützmann R; Hartmann A; Bruns V; Benz M; Schneider-Stock R; Geppert CI
Int J Mol Sci; 2021 Dec; 22(23):. PubMed ID: 34884913
[TBL] [Abstract][Full Text] [Related]
8. Improving tumor budding reporting in colorectal cancer: a Delphi consensus study.
Haddad TS; Lugli A; Aherne S; Barresi V; Terris B; Bokhorst JM; Brockmoeller SF; Cuatrecasas M; Simmer F; El-Zimaity H; Fléjou JF; Gibbons D; Cathomas G; Kirsch R; Kuhlmann TP; Langner C; Loughrey MB; Riddell R; Ristimäki A; Kakar S; Sheahan K; Treanor D; van der Laak J; Vieth M; Zlobec I; Nagtegaal ID
Virchows Arch; 2021 Sep; 479(3):459-469. PubMed ID: 33650042
[TBL] [Abstract][Full Text] [Related]
9. The prognostic influence of tumour budding in Western patients with stage II colorectal cancer.
Canguçu AL; Valério E; Peixoto RBP; Felismino TC; de Mello CAL; Neotti T; Calsavara VF; de Macedo MP; Júnior SA; Riechelmann R
Ecancermedicalscience; 2020; 14():1130. PubMed ID: 33209121
[TBL] [Abstract][Full Text] [Related]
10. Tumour budding and its clinical implications in gastrointestinal cancers.
Zlobec I; Berger MD; Lugli A
Br J Cancer; 2020 Sep; 123(5):700-708. PubMed ID: 32601463
[TBL] [Abstract][Full Text] [Related]
11. Predictive power of tumour budding for lymph node metastasis in colorectal carcinomas: A retrospective study.
Deb B; Jacob SE
Indian J Med Res; 2019 Dec; 150(6):635-639. PubMed ID: 32048628
[TBL] [Abstract][Full Text] [Related]
12. RAS, Cellular Plasticity, and Tumor Budding in Colorectal Cancer.
Maffeis V; Nicolè L; Cappellesso R
Front Oncol; 2019; 9():1255. PubMed ID: 31803624
[TBL] [Abstract][Full Text] [Related]
13. Tumour budding predicts increased recurrence after curative resection for T2N0 colorectal cancer.
Garfinkle R; Lee L; Boutros M; Cardin MJ; Spatz A; Morin N
Can J Surg; 2019 Oct; 62(5):334-339. PubMed ID: 31550095
[TBL] [Abstract][Full Text] [Related]
14. Prospective Multicenter Study on the Prognostic and Predictive Impact of Tumor Budding in Stage II Colon Cancer: Results From the SACURA Trial.
Ueno H; Ishiguro M; Nakatani E; Ishikawa T; Uetake H; Matsuda C; Nakamoto Y; Kotake M; Kurachi K; Egawa T; Yasumasa K; Murata K; Ikawa O; Shinji S; Murotani K; Matsui S; Teramukai S; Tomita N; Sugihara K;
J Clin Oncol; 2019 Aug; 37(22):1886-1894. PubMed ID: 31180819
[TBL] [Abstract][Full Text] [Related]
15. Histopathological Significance and Prognostic Impact of Tumor Budding in Colorectal Cancer.
Mehta A; Goswami M; Sinha R; Dogra A
Asian Pac J Cancer Prev; 2018 Sep; 19(9):2447-2453. PubMed ID: 30255698
[TBL] [Abstract][Full Text] [Related]
16. Newly recognized extratumoral features of colorectal cancer challenge the current tumor-node-metastasis staging system.
Athanasakis E; Xenaki S; Venianaki M; Chalkiadakis G; Chrysos E
Ann Gastroenterol; 2018; 31(5):525-534. PubMed ID: 30174388
[TBL] [Abstract][Full Text] [Related]
17. Automatic evaluation of tumor budding in immunohistochemically stained colorectal carcinomas and correlation to clinical outcome.
Weis CA; Kather JN; Melchers S; Al-Ahmdi H; Pollheimer MJ; Langner C; Gaiser T
Diagn Pathol; 2018 Aug; 13(1):64. PubMed ID: 30153844
[TBL] [Abstract][Full Text] [Related]
18. Tumour budding in rectal cancer. A comprehensive review.
Lino-Silva LS; Salcedo-Hernández RA; Gamboa-Domínguez A
Contemp Oncol (Pozn); 2018; 22(2):61-74. PubMed ID: 30150882
[TBL] [Abstract][Full Text] [Related]
19. Interobserver variability in the H&E-based assessment of tumor budding in pT3/4 colon cancer: does it affect the prognostic relevance?
Martin B; Schäfer E; Jakubowicz E; Mayr P; Ihringer R; Anthuber M; Schenkirsch G; Schaller T; Märkl B
Virchows Arch; 2018 Aug; 473(2):189-197. PubMed ID: 29626253
[TBL] [Abstract][Full Text] [Related]
20. Recommendations for reporting tumor budding in colorectal cancer based on the International Tumor Budding Consensus Conference (ITBCC) 2016.
Lugli A; Kirsch R; Ajioka Y; Bosman F; Cathomas G; Dawson H; El Zimaity H; Fléjou JF; Hansen TP; Hartmann A; Kakar S; Langner C; Nagtegaal I; Puppa G; Riddell R; Ristimäki A; Sheahan K; Smyrk T; Sugihara K; Terris B; Ueno H; Vieth M; Zlobec I; Quirke P
Mod Pathol; 2017 Sep; 30(9):1299-1311. PubMed ID: 28548122
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
